Word count, abstract: 197 Word count, text: 1110 Word count, tables: 373 Word count, references: 478 For personal use only. on October 28, 2017. by guest www.bloodjournal.org From 3 KEY POINTS • It remains unclear if a subgroup of high risk patients could potentially benefit from a more extensive screening strategy. • Age, prior provoked VTE and smoking status may be important predictors of occult cancer detection in patients with first unprovoked VTE. ABSTRACT Unprovoked venous thromboembolism (VTE) may be the earliest indication of cancer. Risk factors predictive of occult cancer detection in patients with a first unprovoked symptomatic VTE are unknown. Cox proportional hazard models and multivariate analyses were performed to assess the effect of specific risk factors on occult cancer detection within one year of a diagnosis of unprovoked VTE in patients randomized in the SOME trial. The SOME trial is a multicenter open-label randomized controlled trial assessing the efficacy for occult cancer screening strategies in patients with a first unprovoked VTE. A total of 33 (3.9%; 95% C.I. 2.8-5.4) out of the 854 included patients received a new diagnosis of cancer at 1-year follow-up. Age
BRIEF REPORT

Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism
≥ 60 years (hazard ratio [HR] of 3.11 (95% C.I. 1.41-6.89, p=0.005), previous provoked VTE (HR=3.20, 95% C.I. 1.19-8.62, p=0.022) and current smoker status (HR=2.80, 95% C.I. 1.24-6.33, p=0.014) were associated with occult cancer detection. Compared with patients without any of these characteristics, the hazard of cancer in patients with one of these risk factors was increased four-fold (HR=4.59, 95% CI: 1.89-11.11). Age, prior provoked VTE and smoking status may be important predictors of occult cancer detection in patients with first unprovoked VTE. The SOME trial is registered to www.clinicaltrials.gov as NCT00773448.
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From INTRODUCTION Venous thromboembolism (VTE), which comprises deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common and potentially fatal condition. [1] [2] [3] Unprovoked events, which occur in the absence of a major thrombogenic risk factor, represent approximately 40% of all VTE. 4 Unprovoked VTE may be the earliest indication of cancer. 5;6 It was previously demonstrated that between 3.2 and 10.0% of patients presenting with unprovoked VTE will be subsequently diagnosed with cancer, with the highest risk in the first year after the diagnosis of VTE. [7] [8] [9] This has led to a debate as to whether an extensive screening for occult cancer in these patients is warranted. Two recently published studies have reported that using an extensive screening strategy is unlikely to provide benefit to all patients with unprovoked episodes of VTE. 9;10 However it remains unclear if a subgroup of high risk patients could potentially benefit from a more extensive occult cancer screening strategy. Identification of risk factors associated with early detection of occult cancers in order to stratify patients with higher risk of cancer detection following an unprovoked VTE might be of potential clinical importance, and provide a basis for effective screening and preventive strategies. We sought to assess the risk factors predictive of occult cancer detection in patients with a first objectively proven unprovoked symptomatic VTE.
METHODS
Post-hoc, pre-defined analyses of the SOME trial 10 were performed. The SOME trial is a multicenter open-label randomized controlled trial of patients with a first unprovoked VTE that compared a limited evaluation for occult cancer screening (basic laboratory For personal use only. on October 28, 2017. by guest www.bloodjournal.org From testing, chest radiography, and breast, cervical, and prostate cancer screening) with a more comprehensive strategy (limited evaluation plus CT of the abdomen and pelvis). 10 Unprovoked VTE was defined as occurring in the absence of known malignant disease in the past 5 years, trauma of the leg or lower-extremity plaster cast, surgery using general anesthesia 3 months previous to the event, immobilization for 3 or more days, previous unprovoked VTE, thrombophilia (hereditary or acquired), and current pregnancy. Methods have been previously described in detail. 10 All patients enrolled (n=854) in the SOME trial were included in the analyses. The 11 Although a prior history of provoked VTE has never been described as an important risk factor for occult cancer detection, it is plausible that patients with prior provoked events (e.g. post-surgery) might be more susceptible to VTE complications in the presence of an underlying occult cancer. Finally, smoking has been associated with oral, lung, colorectal and urothelial cancers. Up to 25% of cancers diagnosed with the trial (colorectal (n=5) and urothelial (n=3)) might have been related to smoking. Our findings may help identify patients with first unprovoked VTE who are at particularly high-risk and who may benefit from closer surveillance and additional testing. Our results need to be validated in other cohort of patients and further prospective studies are needed to assess if occult cancer screening is beneficial in this high risk group of patients.
RESULTS AND DISCUSSION
Our study has a number of strengths including prospective data collection within a multicentre trial, good measurement of a priori identified and potentially important predictors of cancer. Our study has limitations. First, it has a relatively small number of events limiting the ability to adjust for important confounders and to provide actual accurate absolute estimates for each possible risk factor combinations, although it is largest trial population studied on this topic. Nevertheless, we were able to identify clinically relevant predictors for occult cancer. Second, potentially relevant risk factors, such as laboratory measurements, were not collected at study baseline. Finally, the definition of unprovoked VTE is heterogeneous and other clinical settings might have different For personal use only. on October 28, 2017. by guest www.bloodjournal.org From patient's demographics (e.g. older patient population) and therefore, our results might not be generalizable all clinical practices.
In conclusion, age, prior provoked VTE and smoking may be predictors of occult cancer in patients presenting with a first unprovoked VTE. Our results might help to identify patients with acute unprovoked VTE at high risk of underlying cancer. 
